Chemical Property of Bis(2-chloroethyl)ethylamine
Chemical Property:
- Vapor Pressure:7.63mmHg at 25°C
- Melting Point:-33.9°C
- Refractive Index:1.6000 (estimate)
- Boiling Point:135.7°C at 760 mmHg
- PKA:6.48±0.50(Predicted)
- Flash Point:35.9°C
- PSA:3.24000
- Density:1.079g/cm3
- LogP:1.78590
- XLogP3:1.8
- Hydrogen Bond Donor Count:0
- Hydrogen Bond Acceptor Count:1
- Rotatable Bond Count:5
- Exact Mass:169.0425048
- Heavy Atom Count:9
- Complexity:53
- Purity/Quality:
-
98%min *data from raw suppliers
BIS(2-CHLOROETHYL)ETHYLAMINE 95.00% *data from reagent suppliers
Safty Information:
- Pictogram(s):
- Hazard Codes:
- MSDS Files:
-
SDS file from LookChem
Useful:
- Chemical Classes:Toxic Gases & Vapors -> Chemical Weapons
- Canonical SMILES:CCN(CCCl)CCCl
- Inhalation Risk:A harmful contamination of the air will be reached quickly on evaporation of this substance at 20 °C; on spraying or dispersing, however, much faster.
- Effects of Short Term Exposure:Blistering agent. Lachrymation. The substance is severely irritating to the eyes, skin and respiratory tract. The substance may cause effects on the central nervous system and bone marrow. Inhalation may cause lung oedema. The effects may be delayed. Medical observation is indicated.
- Effects of Long Term Exposure:The substance may have effects on the bone marrow and central nervous system. This substance is probably carcinogenic to humans. May cause heritable genetic damage to human germ cells.
-
Uses
Although nitrogen mustards could be
used in chemical warfare, there are presently no
records of such use. HN-1 has been used to
remove warts in the past, Nitrogen mustards are among the blister agents/vesicants used
in chemical warfare. HN-1 was originally designed to remove
warts and later identified as a potential chemical warfare agent.
HN-2 was designed as a military agent, but later used in cancer
chemotherapy. HN-3 was developed as a military chemical
warfare agent. Nitrogen mustards have also found therapeutic
applications in cancer treatment, and there are several pharmaceutical
derivatives that were developed as cancer therapeutic
agents.